Asad Saleem Sial
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Asad Saleem Sial has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Abu Hazafa
Department of Biochemistry, Faculty of Sciences, University of Agriculture, Faisalabad 38040, Pakistan
1 shared publication - Adnan Amin
Department of Life Sciences, Yeungnam University, Gyeongsan 38541, Republic of Korea
1 shared publication Imran Akhtar
Department of Pharmacology, Faculty of Pharmacy and Alternative Medicine, The Islamia University of Bahawalpur, Bahawalpur, Pakistan
1 shared publication- Khizar Abbas
Department of Pharmacognosy, Faculty of Pharmacy, Bahauddin Zakariya University, Multan 60800, Pakistan
1 shared publication Muhammad Mohtasheemul-Hasan
1 shared publication- Muhammad Naeem
College of Life Science, Hebei Normal University, Shijiazhuang 050024, China
1 shared publication
Latest Publications
- 14 March 2026
- Published by Elsevier in South African Journal of Botany
- Vol. 192, 194-205
Nutritional and phytochemical profiling of Solanum melongena L. root extract using LC-ESI-MS/MS; In-silico and biological evaluation
- 14 March 2026
- Published by Elsevier in South African Journal of Botany
- Vol. 192, 194-205
Nutritional and phytochemical profiling of Solanum melongena L. root extract using LC-ESI-MS/MS; In-silico and biological evaluation
- Open Access
- 20 December 2021
- Published by Taylor & Francis in Bioengineered
- Vol. 12 (2) , 12702-12721
The nephroprotective effects of Daucus carota and Eclipta prostrata against cisplatin-induced nephrotoxicity in rats
The overuse of cisplatin (>50 mg/m2) is limited to nephrotoxicity, ototoxicity, gastrotoxicity, myelosuppression, and allergic reactions. The objective of this study was to investigate the nephroprotective effects of Daucus carota and Eclipta prostrata extracts on cisplatin-induced nephrotoxicity in Wistar albino rats. The study involved male Wistar albino rats of 8 weeks weighing 220–270 g. A single injection of 5 mg/kg was injected into the rats for nephrotoxicity. Rats were divided into four groups based on dose conentrations. Blood and urine samples of rats were collected on the 0, 7th, 14th, and 21st days for nephrological analysis. The results showed that Cis + DC/Cis + EP (600 mg/kg) significantly (p < 0.001) increased the body weight and reduced the kidney weight of cisplatin-induced nephrotoxicity in rats (p < 0.001) as compared to Cis group. The results showed that 600 mg/kg administration of Cis + DC/Cis +EP successfully (p < 0.005) improved the urine and plasmin creatinine, Na, and K level compared to the Cis group. Histopathological results confirmed that Cis + EP/Cis + DC effectively improved the renal abnormalities. It is concluded that the co-administration of Cis + EP extract showed exceptional nephroprotective effects at a dose rate of 600 mg/kg.
- 20 December 2021
- Published by Taylor & Francis in Bioengineered
- Vol. 12 (2) , 12702-12721
Open AccessThe nephroprotective effects of Daucus carota and Eclipta prostrata against cisplatin-induced nephrotoxicity in rats
The overuse of cisplatin (>50 mg/m2) is limited to nephrotoxicity, ototoxicity, gastrotoxicity, myelosuppression, and allergic reactions. The objective of this study was to investigate the nephroprotective effects of Daucus carota and Eclipta prostrata extracts on cisplatin-induced nephrotoxicity in Wistar albino rats. The study involved male Wistar albino rats of 8 weeks weighing 220–270 g. A single injection of 5 mg/kg was injected into the rats for nephrotoxicity. Rats were divided into four groups based on dose conentrations. Blood and urine samples of rats were collected on the 0, 7th, 14th, and 21st days for nephrological analysis. The results showed that Cis + DC/Cis + EP (600 mg/kg) significantly (p < 0.001) increased the body weight and reduced the kidney weight of cisplatin-induced nephrotoxicity in rats (p < 0.001) as compared to Cis group. The results showed that 600 mg/kg administration of Cis + DC/Cis +EP successfully (p < 0.005) improved the urine and plasmin creatinine, Na, and K level compared to the Cis group. Histopathological results confirmed that Cis + EP/Cis + DC effectively improved the renal abnormalities. It is concluded that the co-administration of Cis + EP extract showed exceptional nephroprotective effects at a dose rate of 600 mg/kg.